Actonel Femure Fracture Side Effects

Actonel (risedronate sodium) was approved in the United States in 1998 for the treatment of osteoporosis and Paget's disease. While most users are given the drug for many years, recent studies and adverse event reports suggest that long-term use of the drug may increase the risk of low-energy bone fractures, most commonly involving the thigh bone or femur.

Click here to read Howard Raphaelson's full article...